An A<sub>2A </sub>adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models
<p>Abstract</p> <p>Background</p> <p>The pathophysiology of sepsis is due in part to early systemic inflammation. Here we describe molecular and cellular responses, as well as survival, in A<sub>2A </sub>adenosine receptor (AR) agonist treated and untreated...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-10-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/8/141 |